AbbVie Inc.
ABBV 228.38 (-0.45%) 1.04
Health Care
Biotechnology
Quality Checklist 1/8
Est. EPS Growth > 5%
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $403.81(B)
EV: $452.95(B)
Total Equity: $-3.23(B)
Earnings date: Apr-24-2026
P/E: 96.36
Forward P/E: 15.73
P/FCF: 22.66
P/S: 6.61
P/B: N/A
EPS: $2.4
EPS (fwd): $14.5
FCF/share: $10.1
Revenue/share: $34.6
Book value/share: $-1.9
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Debt/Equity: 48
Current Ratio: 0.70
Gross margin: 71.6%
Operating margin: 24.1%
Net margin: 6.9%
Dividend/share: $6.7
Div. yield: 2.91%
Growth Estimates
Revenue
CAGR: 5.5%FY+1$67.07(B)
FY+2(+8.0%)$72.41(B)
FY+3(+7.1%)$77.54(B)
FY+4(+5.1%)$81.51(B)
FY+5(+2.0%)$83.10(B)
Net Income
CAGR: 7.4%FY+1$25.74(B)
FY+2(+10.3%)$28.40(B)
FY+3(+9.5%)$31.10(B)
FY+4(+7.5%)$33.42(B)
FY+5(+2.4%)$34.23(B)
EPS
CAGR: 7.9%FY+1$14.52
FY+2(+10.7%)$16.07
FY+3(+9.6%)$17.61
FY+4(+8.5%)$19.10
FY+5(+2.9%)$19.65
FCF per share
CAGR: 5.2%FY+1$14.54
FY+2(+8.8%)$15.82
FY+3(+7.9%)$17.07
FY+4(+5.1%)$17.93
FY+5(-0.7%)$17.80